Skip to main content
Watch Insiders
AMLX filings

Corporate insider profile

Karen Firestone Filing Activity

Latest reported as Director of Amylyx Pharmaceuticals, Inc. (AMLX).

Purchase filings
1
Reported companies
1
Net open-market value
$51,338
Latest transaction
May 21, 2026

Affiliated corporations

Reported company relationships

AMLXLatest reported

Amylyx Pharmaceuticals, Inc.

Director

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
May 21, 2026Amylyx Pharmaceuticals, Inc. (AMLX)DirectorOpen Market Purchase3,800$13.51$51,338